Literature DB >> 19868207

THERAPEUTIC EXPERIMENTS WITH ROSENOW'S ANTIPOLIOMYELITIC SERUM.

H L Amoss1, F Eberson.   

Abstract

Two series of experiments are described in which Rosenow's anti-poliomyelitic serum, so called, has been compared with the immune serum derived from monkeys which have convalesced or recovered from experimental poliomyelitis. The experiments consisted in introducing an active virus of polio-myelitis into the blood and of injecting the two kinds of serum into the cerebrospinal meninges according to the method of Flexner and Amoss. Under the conditions of the experiment, the control monkeys (a) receiving the virus intravenously alone do not develop paralysis, while those (b) receiving the virus intravenously and normal horse serum intraspinally develop paralysis. Moreover, the monkeys (c) receiving the virus intravenously and Rosenow's antipoliomyelitic serum intraspinally develop paralysis in the manner of those receiving normal horse serum intraspinally. The monkeys (d) which received the virus intravenously and the convalescent or immune monkey serum intraspinally alone did not develop paralysis. The Rosenow serum acts in the manner of normal horse serum; it promotes the passage of the virus of poliomyelitis from the blood into the nervous organs, and it does not protect from infection. We have found no evidence that Rosenow's serum under the conditions of the tests is effective therapeutically in monkeys or possesses antibodies of the same nature as those present in the blood of monkeys which have recovered from experimental poliomyelitis. Since the antibodies in convalescent poliomyelitic serum in man and the monkey are identical, it follows that any antibodies present in the Rosenow horse serum do not conform to those occurring in human convalescent serum.

Entities:  

Year:  1918        PMID: 19868207      PMCID: PMC2125934          DOI: 10.1084/jem.27.2.309

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  ON THE ETIOLOGY OF EPIDEMIC POLIOMYELITIS.

Authors:  E C Rosenow; E B Towne; G W Wheeler
Journal:  Science       Date:  1916-10-27       Impact factor: 47.728

2.  EXPERIMENTS ON THE CULTIVATION OF THE MICROORGANISM CAUSING EPIDEMIC POLIOMYELITIS.

Authors:  S Flexner; H Noguchi
Journal:  J Exp Med       Date:  1913-10-01       Impact factor: 14.307

3.  THE CULTIVATION AND IMMUNOLOGICAL REACTIONS OF THE GLOBOID BODIES IN POLIOMYELITIS.

Authors:  H L Amoss
Journal:  J Exp Med       Date:  1917-04-01       Impact factor: 14.307

4.  LOCALIZATION OF THE VIRUS AND PATHOGENESIS OF EPIDEMIC POLIOMYELITIS.

Authors:  S Flexner; H L Amoss
Journal:  J Exp Med       Date:  1914-09-01       Impact factor: 14.307

5.  A REPORT ON THE SERUM TREATMENT OF TWENTY-SIX CASES OF EPIDEMIC POLIOMYELITIS.

Authors:  H L Amoss; A M Chesney
Journal:  J Exp Med       Date:  1917-04-01       Impact factor: 14.307

6.  THE RELATION OF THE MENINGES AND CHOROID PLEXUS TO POLIOMYELITIC INFECTION.

Authors:  S Flexner; H L Amoss
Journal:  J Exp Med       Date:  1917-04-01       Impact factor: 14.307

7.  THE PATHOLOGIC EFFECTS OF STREPTOCOCCI FROM CASES OF POLIOMYELITIS AND OTHER SOURCES.

Authors:  C G Bull
Journal:  J Exp Med       Date:  1917-04-01       Impact factor: 14.307

8.  A CONTRIBUTION TO THE BACTERIOLOGY OF ACUTE ANTERIOR POLIOMYELITIS.

Authors:  J A Kolmer; C P Brown; A M Freese
Journal:  J Exp Med       Date:  1917-06-01       Impact factor: 14.307

9.  THE PASSAGE OF NEUTRALIZING SUBSTANCES FROM THE BLOOD INTO THE CEREBROSPINAL FLUID IN POLIOMYELITIS.

Authors:  S Flexner; H L Amoss
Journal:  J Exp Med       Date:  1917-04-01       Impact factor: 14.307

  9 in total
  2 in total

1.  IMMUNOLOGICAL DISTINCTIONS OF ENCEPHALITIS AND POLIOMYELITIS.

Authors:  H L Amoss
Journal:  J Exp Med       Date:  1921-01-31       Impact factor: 14.307

2.  AN EXPERIMENTAL TEST OF NUZUM'S ANTIPOLIOMYELITIC SERUM.

Authors:  H L Amoss; F Eberson
Journal:  J Exp Med       Date:  1918-09-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.